A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.
Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A.
Montagner IM, et al. Among authors: grigoletto a.
J Control Release. 2016 Aug 28;236:79-89. doi: 10.1016/j.jconrel.2016.06.033. Epub 2016 Jun 26.
J Control Release. 2016.
PMID: 27356018
Free article.